Efficacy and safety of insulin aspart in a fixed or flexible supplementary insulin therapy regimen, with or without insulin detemir in type 2 diabetes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin aspart; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 21 Nov 2014 Biomarkers information updated
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 12 Jul 2011 Planned patient number is 400, inclusion and exclusion criteria amended as reported by EudraCT.